CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 81,808	$ 30,294
Restricted cash	1,549	66,196
Patient accounts receivable	255,145	237,596
Prepaid expenses	10,217	8,243
Other current assets	13,265	8,225
Total current assets	361,984	350,554
Property and equipment, net of accumulated depreciation of $95,024 and $96,137	23,719	28,113
Operating lease right of use assets	93,440	84,791
Goodwill	932,685	658,500
Intangible assets, net of accumulated amortization of $22,973 and $7,044	74,183	64,748
Deferred income taxes	47,987	21,427
Other assets	33,200	54,612
Total assets	1,567,198	1,262,745
Current liabilities:
Accounts payable	42,674	31,259
Payroll and employee benefits	146,929	120,877
Accrued expenses	166,192	137,111
Provider relief fund advance	60,000	0
Current portion of long-term obligations	10,496	9,927
Current portion of operating lease liabilities	30,046	27,769
Total current liabilities	456,337	326,943
Long-term obligations, less current portion	204,511	232,256
Operating lease liabilities, less current portion	61,987	56,128
Other long-term obligations	33,622	5,905
Total liabilities	756,457	621,232
Commitments and Contingencies
Equity:
Preferred stock, $0.001 par value, 5,000,000 shares authorized; none issued or outstanding	0	0
Common stock, $0.001 par value, 60,000,000 shares authorized; 37,470,212 and 36,638,021 shares issued; and 32,814,278 and 32,284,051 shares outstanding	38	37
Additional paid-in capital	698,287	645,256
Treasury stock at cost, 4,655,934 and 4,353,970 shares of common stock	(319,092)	(251,241)
Accumulated other comprehensive income	0	15
Retained earnings	429,991	246,383
Total Amedisys, Inc. stockholders’ equity	809,224	640,450
Noncontrolling interests	1,517	1,063
Total equity	810,741	641,513
Total liabilities and equity	$ 1,567,198	$ 1,262,745